Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#81 / 200 Total
TISI - Team, Inc. - Stock Price Chart
TickerTISI [NYSE]
CompanyTeam, Inc.
CountryUSA
IndustrySpecialty Business Services
Market Cap26.56MEPS (ttm)-17.33
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y3.80%
P/S0.03EPS next 5Y11.00%
P/B0.58EPS Q/Q-115.48%
Dividend-Sales Q/Q1.34%
Insider Own2.73%Inst Own48.52%
Insider Trans-Inst Trans-22.54%
Short Float0.34%EarningsMar 07/a
Analyst Recom3.00Target Price13.00
Avg Volume12.94K52W Range3.53 - 11.25
Apr-23-24 06:51AM WEEX Exchange Unveils WXT Token to Enhance Ecosystem and Reward Community Engagement (Insider Monkey)
Apr-08-24 04:30PM Team, Inc. Appoints Pamela J. McGinnis to Its Board of Directors (GlobeNewswire) -13.07%
Mar-15-24 04:45PM Team, Inc. Receives Continued Listing Standard Notice From NYSE (GlobeNewswire)
Mar-07-24 05:22PM Team: Q4 Earnings Snapshot (Associated Press Finance) +6.41%
04:45PM Team, Inc. Reports Fourth Quarter and Full Year 2023 Results (GlobeNewswire)
Nov-09-23 06:33PM Team: Q3 Earnings Snapshot (Associated Press Finance)
04:45PM Team, Inc. Reports Third Quarter 2023 Results (GlobeNewswire)
Nov-08-23 07:44AM Team Inc. Names Michael Caliel as Executive Chairman (Hart Energy)
Nov-07-23 06:45AM Team, Inc. Names Michael J. Caliel as Executive Chairman (GlobeNewswire) -6.57%
Aug-10-23 05:11PM Team: Q2 Earnings Snapshot (Associated Press Finance)
AGBA - AGBA Group Holding Limited - Stock Price Chart
TickerAGBA [NASD]
CompanyAGBA Group Holding Limited
CountryHong Kong
IndustryCapital Markets
Market Cap248.46MEPS (ttm)-0.75
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-332.18%
P/S4.59EPS next 5Y-
P/B28.30EPS Q/Q-322.41%
Dividend-Sales Q/Q-
Insider Own0.00%Inst Own0.04%
Insider Trans-Inst Trans0.47%
Short Float0.03%EarningsNov 14/b
Analyst Recom-Target Price-
Avg Volume11.44M52W Range0.32 - 4.29
Apr-30-24 12:45PM AGBA Stock Pops 35% on Triller Merger Update (InvestorPlace) +20.43%
09:00AM Building a Digital Economy Titan: AGBA and Triller Combine in $4 Billion Merger (GlobeNewswire)
Apr-25-24 04:15PM AGBA Stands Firm: The AGBA-Triller Merger is Value-Enhancing to All Stakeholders (GlobeNewswire) -8.57%
Apr-22-24 10:57AM BestGrowthStocks.com Unveils In-Depth Review of Triller Merger with AGBA Group Holding Limited (News Direct) +100.00%
Apr-19-24 08:32AM AGBA/TRILLER $4 billion MERGER: ELEVATING SHAREHOLDER VALUE TO NEW HEIGHTS - IMMEDIATELY AND FOR THE LONG TERM (GlobeNewswire) +21.36%
Apr-18-24 08:00AM AGBA and Triller Merge to Create a $4 Billion Powerhouse, Unleashing a Game-Changing Power in Digital Content and Financial Services (GlobeNewswire) +157.50%
Mar-28-24 04:10PM AGBA Announces Fourth Quarter 2023 Earnings, Amid Challenging Macro Environment. (GlobeNewswire)
Mar-06-24 07:00AM Presenting on the Emerging Growth Conference 68 Day 2 on March 7 Register Now (GlobeNewswire)
Mar-05-24 07:00AM Presenting on the Emerging Growth Conference 68 Day 1 on March 6 Register Now (GlobeNewswire)
05:00AM Asian Financial Services Stocks Could Soar As Economic Tailwinds Intensify (News Direct)
TTOO - T2 Biosystems Inc - Stock Price Chart
TickerTTOO [NASD]
CompanyT2 Biosystems Inc
CountryUSA
IndustryDiagnostics & Research
Market Cap20.11MEPS (ttm)-145.61
P/E-EPS this Y74.36%
Forward P/E-EPS next Y76.01%
PEG-EPS past 5Y68.62%
P/S2.80EPS next 5Y-
P/B-EPS Q/Q98.19%
Dividend-Sales Q/Q-69.38%
Insider Own90.77%Inst Own3.96%
Insider Trans0.00%Inst Trans23.05%
Short Float73.43%EarningsMay 06/a
Analyst Recom3.00Target Price3.50
Avg Volume308.84K52W Range2.60 - 70.00
Apr-24-24 09:00AM T2 Biosystems to Report First Quarter 2024 Financial Results and Business Updates on May 6, 2024 (GlobeNewswire)
Apr-23-24 07:39AM Top Premarket Decliners (MT Newswires) -13.92%
Apr-11-24 04:05PM T2 Biosystems Shareholders Vote for CRG Debt Conversion into Equity (GlobeNewswire)
Mar-28-24 09:00AM T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc. (GlobeNewswire)
Mar-20-24 07:30AM T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business Updates (GlobeNewswire) -10.89%
Mar-19-24 09:00AM T2 Biosystems to Host Investor Call on March 20, 2024 to Unveil its T2Lyme Launch Plans and Provide Additional Business Updates (GlobeNewswire) -11.20%
Mar-18-24 09:00AM T2 Biosystems Announces New Publication Highlighting the Clinical Benefits and Performance of the T2Resistance Panel (GlobeNewswire) -5.98%
Mar-12-24 03:16PM TTOO Stock: T2 Biosystems Has Until May 20 to Regain Nasdaq Compliance (InvestorPlace)
09:00AM T2 Biosystems Receives Extension to Comply with Nasdaq Listing Requirement (GlobeNewswire)
Feb-16-24 09:29AM T2 Biosystems, Inc. (NASDAQ:TTOO) Q4 2023 Earnings Call Transcript (Insider Monkey) -14.71%
ARAY - Accuray Inc - Stock Price Chart
TickerARAY [NASD, RUT]
CompanyAccuray Inc
CountryUSA
IndustryMedical Devices
Market Cap152.72MEPS (ttm)-0.22
P/E-EPS this Y-57.50%
Forward P/E24.32EPS next Y140.21%
PEG-EPS past 5Y19.06%
P/S0.35EPS next 5Y-
P/B3.20EPS Q/Q-1130.65%
Dividend-Sales Q/Q-14.34%
Insider Own5.76%Inst Own65.11%
Insider Trans-3.77%Inst Trans-4.19%
Short Float5.82%EarningsMay 01/a
Analyst Recom1.00Target Price6.00
Avg Volume546.18K52W Range2.10 - 4.30
May-02-24 10:45AM Accuray Incorporated (NASDAQ:ARAY) Q3 2024 Earnings Call Transcript (Insider Monkey) -29.03%
09:16AM Accuray (ARAY) Q3 Earnings Lag Estimates, Gross Margin Contracts (Zacks)
06:28AM Q3 2024 Accuray Inc Earnings Call (Thomson Reuters StreetEvents)
03:36AM Accuray Inc (ARAY) Q3 2024 Earnings Call Transcript Highlights: Navigating Challenges and ... (GuruFocus.com)
May-01-24 05:59PM Accuray Inc (ARAY) Faces Challenges in Fiscal Q3 2024, Misses Revenue Expectations (GuruFocus.com)
05:45PM Accuray (ARAY) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:43PM Accuray: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
04:06PM Accuray Reports Fiscal 2024 Third Quarter Financial Results (PR Newswire)
Apr-25-24 07:35AM Accuray Showcases Advances in Radiation Therapy Solutions Designed to Improve the Cancer Treatment Experience at ESTRO 2024 (PR Newswire)
Apr-18-24 07:35AM Accuray Expands Global Training Center Network With Opening of New Facility in Genolier, Switzerland (PR Newswire)
NKGN - NKGen Biotech Inc - Stock Price Chart
TickerNKGN [NASD]
CompanyNKGen Biotech Inc
CountryUSA
IndustryBiotechnology
Market Cap29.69MEPS (ttm)-4.10
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-989.64%
Dividend-Sales Q/Q-
Insider Own60.46%Inst Own14.37%
Insider Trans0.01%Inst Trans14.10%
Short Float4.77%Earnings-
Analyst Recom-Target Price-
Avg Volume3.64M52W Range0.78 - 12.88
Apr-29-24 08:00AM NKGen Biotech Announces FDA Clearance of Investigational New Drug (IND) Application for SNK01 NK Cell Therapy in Parkinsons Disease (GlobeNewswire)
Apr-25-24 04:05PM NKGen Biotech Presents Updated NK Cell Therapy Data for Neurodegenerative Disease at the 12th Annual Alzheimer's & Parkinson's Drug Development Summit (GlobeNewswire) +15.79%
Apr-24-24 04:45PM NKGen Biotech Announces Upcoming Publication at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting (GlobeNewswire) -7.57%
Apr-18-24 04:05PM NKGen Biotech Announces Upcoming Presentation on SNK01 NK Cell Therapy in Neurodegenerative Disease at the 12th Annual Alzheimer's & Parkinson's Drug Development Summit (GlobeNewswire) -16.50%
Apr-16-24 11:53PM NKGN Stock Earnings: NKGen Biotech Reported Results for Q4 2023 (InvestorPlace)
Apr-11-24 08:05AM NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs (GlobeNewswire)
Mar-25-24 04:05PM NKGen Biotech Presents Additional Phase 1 Clinical Trial Data in Alzheimer's Disease at the Tau2024 Global Conference (GlobeNewswire) -6.90%
Mar-06-24 07:52AM Why Is NKGen Biotech (NKGN) Stock Up 62% Today? (InvestorPlace) +112.30%
Mar-04-24 08:00AM NKGen Biotech Announces Upcoming Presentation on SNK01 in Alzheimer's Disease at the Tau2024 Global Conference (GlobeNewswire)
Feb-07-24 08:57AM Passage of the Amendment to the Advanced Regenerative Biotech Act a Positive Catalyst for Korean and Japanese Cell Therapy Companies (News Direct)
GREE - Greenidge Generation Holdings Inc - Stock Price Chart
TickerGREE [NASD]
CompanyGreenidge Generation Holdings Inc
CountryUSA
IndustryCapital Markets
Market Cap22.71MEPS (ttm)-3.32
P/E-EPS this Y72.06%
Forward P/E-EPS next Y-43.16%
PEG-EPS past 5Y36.24%
P/S0.31EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q26.67%
Insider Own33.24%Inst Own6.52%
Insider Trans0.18%Inst Trans7.88%
Short Float5.86%EarningsMay 02/a
Analyst Recom1.00Target Price6.00
Avg Volume273.35K52W Range1.55 - 9.26
May-01-24 04:00PM Greenidge Generation Announces Preliminary Financial and Operating Results for the First Quarter 2024 and Release of Investor Presentation (Business Wire)
Apr-29-24 09:00AM Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV (ACCESSWIRE)
Apr-10-24 08:30AM Greenidge Generation: Q4 Profit Beats Its Previous Guidance (RTT News) -8.02%
08:00AM Greenidge Generation Reports Financial and Operating Results for the Fourth Quarter and Full Year 2023 (Business Wire)
Apr-04-24 09:00AM Greenidge Announces Continued Expansion of Power Capacity; Company Has Secured Access To 60 MW of Low-Cost Power in South Carolina (Business Wire)
Mar-27-24 04:00PM Greenidge Generation Announces Fourth Quarter Results Will Meet or Exceed Preliminary Results (Business Wire) +7.38%
Mar-11-24 09:00AM Greenidge Announces Expansion of Power Capacity with 40 MW of Low-Cost Power in Key Territories (Business Wire)
Feb-12-24 09:00AM Infinite Reality, the Global Leader in Immersive Experiences, Acquires Spatial Web Pioneer Ethereal Engine (GlobeNewswire) +6.51%
08:00AM Greenidge Generation Announces $6 Million Investment to Support Ongoing Business Transformation (Business Wire)
Feb-01-24 08:00AM Greenidge Generation Announces Favorable Preliminary Financial and Operating Results for the Fourth Quarter 2023 (Business Wire)
WEAV - Weave Communications Inc - Stock Price Chart
TickerWEAV [NYSE, RUT]
CompanyWeave Communications Inc
CountryUSA
IndustrySoftware - Application
Market Cap613.98MEPS (ttm)-0.44
P/E-EPS this Y75.33%
Forward P/E87.68EPS next Y433.24%
PEG-EPS past 5Y4.39%
P/S3.45EPS next 5Y-
P/B8.36EPS Q/Q14.26%
Dividend-Sales Q/Q19.23%
Insider Own8.76%Inst Own47.60%
Insider Trans-0.35%Inst Trans6.02%
Short Float1.36%EarningsMay 01/a
Analyst Recom1.57Target Price14.86
Avg Volume427.98K52W Range4.04 - 13.80
May-02-24 07:16AM Q1 2024 Weave Communications Inc Earnings Call (Thomson Reuters StreetEvents) -20.86%
03:36AM Weave Communications Inc (WEAV) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue ... (GuruFocus.com)
May-01-24 06:00PM Weave Communications Q1 2024 Earnings: Surpasses Revenue Estimates Amidst Challenges (GuruFocus.com)
04:05PM Weave Announces First Quarter 2024 Financial Results (Business Wire)
Apr-22-24 06:15PM Weave Communications, Inc. (WEAV) Advances But Underperforms Market: Key Facts (Zacks)
Apr-17-24 07:15PM Weave Announces Date of First Quarter 2024 Financial Results and Conference Call (Business Wire)
Apr-16-24 06:15PM Weave Communications, Inc. (WEAV) Flat As Market Gains: What You Should Know (Zacks)
05:07PM UiPath (PATH) and Weave Communications (WEAV) Are Aggressive Growth Stocks (Zacks)
Apr-15-24 09:01AM Weave Now Integrates with Shepherd (Business Wire)
Apr-10-24 12:57PM Weave Named to the 2024 Women Tech Council Shatter List for Third Consecutive Year (Business Wire)
KAVL - Kaival Brands Innovations Group Inc - Stock Price Chart
TickerKAVL [NASD]
CompanyKaival Brands Innovations Group Inc
CountryUSA
IndustryTobacco
Market Cap13.64MEPS (ttm)-3.79
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-252.44%
P/S0.99EPS next 5Y-
P/B1.16EPS Q/Q31.77%
Dividend-Sales Q/Q27.14%
Insider Own70.51%Inst Own1.86%
Insider Trans0.00%Inst Trans-82.26%
Short Float11.03%EarningsMar 27/b
Analyst Recom1.00Target Price5.00
Avg Volume2.51M52W Range1.11 - 20.27
Mar-27-24 08:30AM Kaival Brands Reports Fiscal 2024 First Quarter Financial Results and Provides Business Update (GlobeNewswire) -13.54%
Mar-21-24 07:49AM Why Is Kaival Brands Innovations (KAVL) Stock Up 77% Today? (InvestorPlace) +118.80%
Feb-14-24 04:15PM Kaival Brands Provides Business Update in Letter to Shareholders (GlobeNewswire)
Jan-29-24 08:15AM Kaival Brands Partner Bidi Vapor to Contest FDA Denial of 'Classic' Tobacco-Flavored ENDS (GlobeNewswire) +6.81%
Jan-23-24 08:15AM Kaival Brands Innovations Group Announces Reverse Stock Split (GlobeNewswire) -6.18%
Dec-28-23 08:30AM Kaival Brands Appoints Executive Chairman Barry Hopkins as Interim Chief Executive Officer and President (GlobeNewswire) +9.10%
Dec-07-23 08:30AM Kaival Brands Appoints James W. Dobbins as Senior Vice President, General Counsel (GlobeNewswire) +16.94%
Nov-29-23 11:25AM Kaival Brands, Exclusive Distributor of Bidi Vapor Products to the E-Cigarette and Vape Industry, Featured in InvestmentPitch Media Video (Newsfile) +22.67%
Nov-13-23 08:15AM Kaival Brands Expands Senior Management Team with the Appointment of Barry Hopkins as Executive Chairman (GlobeNewswire)
Nov-07-23 08:15AM Kaival Brands Leads the Way in Compliance as FDA Ramps Up Enforcement of Illicit Vape Products (GlobeNewswire)
OCUL - Ocular Therapeutix Inc - Stock Price Chart
TickerOCUL [NASD, RUT]
CompanyOcular Therapeutix Inc
CountryUSA
IndustryBiotechnology
Market Cap872.46MEPS (ttm)-1.26
P/E-EPS this Y17.45%
Forward P/E-EPS next Y-3.15%
PEG-EPS past 5Y8.38%
P/S14.93EPS next 5Y-
P/B7.41EPS Q/Q-71.51%
Dividend-Sales Q/Q5.16%
Insider Own9.13%Inst Own45.25%
Insider Trans21.76%Inst Trans-1.60%
Short Float10.85%EarningsMay 07/a
Analyst Recom1.38Target Price15.50
Avg Volume2.60M52W Range2.00 - 11.31
Today 07:30AM Ocular Therapeutix To Present at Two Ophthalmology Meetings, May 4-9, 2024 (GlobeNewswire)
May-01-24 07:30AM Ocular Therapeutix to Host Investor Day in New York City on Thursday, June 13, 2024 (GlobeNewswire) +5.91%
Apr-24-24 08:30AM 2 Small-Cap Growth Stocks With Room to Run (Motley Fool) -7.10%
Apr-18-24 03:37PM Ocular Therapeutix Highlights Early Data From Diabetes-Related Eye Disorder (Benzinga) -22.69%
07:00AM Ocular Therapeutix Announces Positive Topline Phase 1 Data for AXPAXLI in Diabetic Retinopathy (GlobeNewswire)
Apr-16-24 04:30PM The 3 Best Biotech Stocks to Buy Now: Q2 Edition (InvestorPlace)
07:00AM Ocular Therapeutix Strengthens Clinical Team with Appointment of Key Retinal Leaders (GlobeNewswire)
Apr-15-24 07:00AM Ocular Therapeutix Executive Chairman Pravin U. Dugel, MD Becomes President and CEO Antony Mattessich is Stepping Down as President and CEO (GlobeNewswire)
Apr-09-24 09:35AM Down -17.88% in 4 Weeks, Here's Why Ocular Therapeutix (OCUL) Looks Ripe for a Turnaround (Zacks)
07:30AM Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Senior Vice President of Global Head of Biometrics (GlobeNewswire)
ORGO - Organogenesis Holdings Inc - Stock Price Chart
TickerORGO [NASD, RUT]
CompanyOrganogenesis Holdings Inc
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap328.58MEPS (ttm)0.04
P/E67.85EPS this Y-93.21%
Forward P/E29.88EPS next Y1149.93%
PEG28.15EPS past 5Y-
P/S0.76EPS next 5Y2.41%
P/B1.17EPS Q/Q-107.57%
Dividend-Sales Q/Q-13.73%
Insider Own41.47%Inst Own44.63%
Insider Trans-0.78%Inst Trans-5.27%
Short Float10.77%EarningsMay 09/a
Analyst Recom1.67Target Price4.83
Avg Volume892.00K52W Range1.88 - 4.70
May-02-24 07:00AM Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis (GlobeNewswire)
Apr-16-24 07:30AM Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024 (GlobeNewswire)
Apr-03-24 07:30AM Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud Case (GlobeNewswire) +6.13%
Mar-02-24 08:39AM Organogenesis Holdings Inc. (NASDAQ:ORGO) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-01-24 06:29PM Why Organogenesis Holding Stock Plummeted by 18% Today (Motley Fool) -18.21%
Feb-29-24 05:45PM Organogenesis (ORGO) Reports Break-Even Earnings for Q4 (Zacks)
04:50PM Organogenesis: Q4 Earnings Snapshot (Associated Press Finance)
04:38PM Organogenesis Holdings Inc (ORGO) Faces Revenue Decline in Q4 and FY 2023, Aims for Growth in 2024 (GuruFocus.com)
04:05PM Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Guidance (GlobeNewswire)
Feb-12-24 07:30AM Organogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference (GlobeNewswire) +5.21%
1⋯4567891011121314⋯20
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.